Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Assets Average (2019 - 2025)

Arcturus Therapeutics Holdings' Assets Average history spans 7 years, with the latest figure at $276.7 million for Q4 2025.

  • For Q4 2025, Assets Average fell 22.56% year-over-year to $276.7 million; the TTM value through Dec 2025 reached $276.7 million, down 22.56%, while the annual FY2025 figure was $307.6 million, 20.46% down from the prior year.
  • Assets Average reached $276.7 million in Q4 2025 per ARCT's latest filing, down from $295.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $479.0 million in Q1 2021 to a low of $276.7 million in Q4 2025.
  • Average Assets Average over 5 years is $389.4 million, with a median of $391.7 million recorded in 2024.
  • Peak YoY movement for Assets Average: skyrocketed 521.03% in 2021, then decreased 28.61% in 2022.
  • A 5-year view of Assets Average shows it stood at $413.7 million in 2021, then fell by 10.07% to $372.0 million in 2022, then rose by 19.23% to $443.5 million in 2023, then fell by 19.43% to $357.4 million in 2024, then fell by 22.56% to $276.7 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Assets Average are $276.7 million (Q4 2025), $295.8 million (Q3 2025), and $320.5 million (Q2 2025).